We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy.
- Authors
Despierre, Evelyn; Vergote, Ignace; Anderson, Ryan; Coens, Corneel; Katsaros, Dionyssios; Hirsch, Fred; Boeckx, Bram; Varella-Garcia, Marileila; Ferrero, Annamaria; Ray-Coquard, Isabelle; Berns, Els; Casado, Antonio; Lambrechts, Diether; Jimeno, Antonio; Hirsch, Fred R; Berns, Els M J J; European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group (EORTC-GCG), Groupe d’Investigateurs Nationaux pour les Etudes des Cancers de l’Ovaire (GINECO); European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group (EORTC-GCG); Groupe d’Investigateurs Nationaux pour les Etudes des Cancers de l’Ovaire (GINECO); Austrian Arbeitsgemeinschaft für Gynäkologische Onkologie (A-AGO)
- Publication
Targeted Oncology, 2015, Vol 10, Issue 4, p583
- ISSN
1776-2596
- Publication type
journal article
- DOI
10.1007/s11523-015-0369-6